Avanos medical, inc. reports preliminary fourth quarter and full-year 2023 financial results; revises preliminary 2024 revenue outlook

Alpharetta, ga. , jan. 4, 2024 /prnewswire/ -- avanos medical, inc. (nyse: avns) today reported selected, unaudited preliminary financial results for the fourth quarter and full-year ended december 31, 2023 and revised its preliminary revenue outlook for 2024.
AVNS Ratings Summary
AVNS Quant Ranking